NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today the closing of its previously …

[Read more...] about Celsus Therapeutics Announces the Closing of $9.2 Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional ADSs

NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX)(formerly OTCQB:CLSXD), an emerging growth, development-stage biotech company, announced today the …

[Read more...] about Celsus Therapeutics Announces Pricing of Public Offering and Listing on NASDAQ

NEW YORK AND LONDON Celsus Therapeutics (OTCQB: CLSXY), an emerging growth, development-stage biopharmaceutical company, announces the appointment of Pablo …

[Read more...] about Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer